MULTIPLE TRITIUM LABELING OF (+)-7-CHLORO-8-HYDROXY-1-PHENYL-3-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE (SCH23390)

被引:16
作者
WYRICK, SD [1 ]
MCDOUGALD, DL [1 ]
MAILMAN, RB [1 ]
机构
[1] UNIV N CAROLINA,SCH MED,DEPT NEUROPHARMACOL,CHAPEL HILL,NC 27514
关键词
D O I
10.1002/jlcr.2580230702
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:685 / 692
页数:8
相关论文
共 5 条
[1]  
MAILMAN R B, 1985, Society for Neuroscience Abstracts, V11, P313
[2]   [H-3] SCH23390 HAS THE CHARACTERISTICS OF A DOPAMINE RECEPTOR LIGAND IN THE RAT CENTRAL NERVOUS-SYSTEM [J].
SCHULZ, DW ;
WYRICK, SD ;
MAILMAN, RB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 106 (01) :211-212
[3]   BINDING OF [H-3] SCH23390 IN RAT-BRAIN - REGIONAL DISTRIBUTION AND EFFECTS OF ASSAY CONDITIONS AND GTP SUGGEST INTERACTIONS AT A D1-LIKE DOPAMINE RECEPTOR [J].
SCHULZ, DW ;
STANFORD, EJ ;
WYRICK, SW ;
MAILMAN, RB .
JOURNAL OF NEUROCHEMISTRY, 1985, 45 (05) :1601-1611
[4]   TRITIUM LABELED (+/-)-7-CHLORO-8-HYDROXY-3-METHYL-1-PHENYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE (SCH23390) [J].
WYRICK, SD ;
MAILMAN, RB .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1985, 22 (02) :189-195
[5]  
1982, Patent No. 4349472